日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Awaji et al. Chemotherapeutic Activity of Imidazolium-Supported Pd(II) o-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells. Pharmaceuticals 2023, 16, 1711

更正:Awaji 等人,《咪唑负载的 Pd(II) o-香草醛二氨基环己烷配合物固定在纳米脂质体中作为乳腺癌细胞中 HER2/neu 和 FGFR2/FGF2 轴过表达抑制剂的化疗活性》,Pharmaceuticals 2023, 16, 1711

Awaji, Aeshah A; Rizk, Moustafa A; Alsaiari, Raiedhah A; Alqahtani, Norah F; Al-Qadri, Fatima A; Alkorbi, Ali S; Hafez, Hani S; Elshaarawy, Reda F M

Threonine and tyrosine kinase (TTK) mRNA and protein expression in breast cancer; prognostic significance in the neoadjuvant setting

乳腺癌中苏氨酸和酪氨酸激酶 (TTK) mRNA 和蛋白表达;新辅助治疗中的预后意义

Ashi, Abrar; Awaji, Aeshah A; Bond, Jacquelyn; Johnson, Colin A; Shaaban, Abeer M; Bell, Sandra M

Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia

纤维肌痛患者 miR-217 和 miR-532 的生化分析

Ayoub, Shymaa E; Ahmed, Azza M; Abdelwahed, Mostafa Y; Khalefa, Abeer A; Awaji, Aeshah A; Zekry, Samer S; Ibrahim, Enas G; Eid, Hana M; Elasmer, Shimaa M; Fares, Reham

Serum Circ-DLGAP4 and miR-9 as Potential Biomarkers in Pancreatic Cancer.

血清 Circ-DLGAP4 和 miR-9 作为胰腺癌的潜在生物标志物

Ali Marwa A, Shaker Olfat G, Ezzat Eman M, Ahmed Mohamed Saad Zaghloul, Elasmer Shimaa Mohammed, Abdelhafeez Marwa Mamdouh Ahmed, Zaidan Mohamed, El-Ela Raghda Yahia Abu, AbdelHafez Marwa N, Fares Eman, Al Abdulqader Ahmad A, Awaji Aeshah A, Alamoudi Mariam K, Abdelaleem Omayma O

RNA binding proteins (RBPs) on genetic stability and diseases

RNA结合蛋白(RBPs)对遗传稳定性和疾病的影响

Aborode, Abdullahi Tunde; Abass, Ohilebo Abdulateef; Nasiru, Shaibu; Eigbobo, Mary Ugunnushe; Nefishatu, Sumana; Idowu, Abdullahi; Tiamiyu, Zainab; Awaji, Aeshah A; Idowu, Nike; Busayo, Babawale Roqeeb; Mehmood, Qasim; Onifade, Isreal Ayobami; Fakorede, Sodiq; Akintola, Ashraf Akintayo

Predictive identification and design of potent inhibitors targeting resistance-inducing candidate genes from E. coli whole-genome sequences

从大肠杆菌全基因组序列中预测性鉴定和设计靶向抗性诱导候选基因的高效抑制剂

Aborode, Abdullahi Tunde; Kumar, Neeraj; Olowosoke, Christopher Busayo; Ibisanmi, Tope Abraham; Ayoade, Islamiyyah; Umar, Haruna Isiyaku; Jamiu, Abdullahi Temitope; Bolarinwa, Basit; Olapade, Zainab; Idowu, Abidemi Ruth; Adelakun, Ibrahim O; Onifade, Isreal Ayobami; Akangbe, Benjamin; Abacheng, Modesta; Ikhimiukor, Odion O; Awaji, Aeshah A; Adesola, Ridwan Olamilekan

Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies

通过分子对接研究,开发出一类具有强效抗癌活性和多靶点酶抑制作用的新型苯基吡唑并[3,4-d]嘧啶类似物。

Aljohani, Ahmed K B; El Zaloa, Waheed Ali Zaki; Alswah, Mohamed; Seleem, Mohamed A; Elsebaei, Mohamed M; Bayoumi, Ashraf H; El-Morsy, Ahmed M; Almaghrabi, Mohammed; Awaji, Aeshah A; Hammad, Ali; Alsulaimany, Marwa; Ahmed, Hany E A

Approaching COVID-19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa

利用流行病学基因组监测应对新冠肺炎疫情以及非洲生物多样性信息学的可持续性

Aborode, Abdullahi Tunde; Huang, Helen; Wireko, Andrew Awuah; Mehta, Aashna; Kalmanovich, Jacob; Abdul-Rahman, Toufik; Sikora, Vladyslav; Awaji, Aeshah A

Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach

MDM2作为脑低级别胶质瘤预后生物标志物的研究及生物活性植物化学物质抑制p53-MDM2通路:一种计算药物开发方法

Biswas, Partha; Bibi, Shabana; Yousafi, Qudsia; Mehmood, Asim; Saleem, Shahzad; Ihsan, Awais; Dey, Dipta; Hasan Zilani, Md Nazmul; Hasan, Md Nazmul; Saleem, Rasha; Awaji, Aeshah A; Fahmy, Usama A; Abdel-Daim, Mohamed M

Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges

基于微针的天然多糖药物递送系统(DDS):进展与挑战

Damiri, Fouad; Kommineni, Nagavendra; Ebhodaghe, Samuel Ogbeide; Bulusu, Raviteja; Jyothi, Vaskuri G S Sainaga; Sayed, Amany A; Awaji, Aeshah A; Germoush, Mousa O; Al-Malky, Hamdan S; Nasrullah, Mohammed Z; Rahman, Md Habibur; Abdel-Daim, Mohamed M; Berrada, Mohammed